These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37676831)

  • 21. Persistence of racial disparities in early-stage lung cancer treatment.
    Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
    Landrum MB; Keating NL; Lamont EB; Bozeman SR; Krasnow SH; Shulman L; Brown JR; Earle CC; Rabin M; McNeil BJ
    J Clin Oncol; 2012 Apr; 30(10):1072-9. PubMed ID: 22393093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
    Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
    Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
    El Brahimi S; Smith ML; Pinheiro PS
    Int J Colorectal Dis; 2019 Aug; 34(8):1467-1475. PubMed ID: 31289849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis.
    Liang PS; Mayer JD; Wakefield J; Trinh-Shevrin C; Kwon SC; Sherman SE; Ko CW
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00155. PubMed ID: 32352722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
    Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
    J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016.
    Chhatre S; Murgu S; Vachani A; Jayadevappa R
    Medicine (Baltimore); 2022 Mar; 101(11):. PubMed ID: 35356921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay.
    Zipkin R; Schaefer A; Chamberlin M; Onega T; O'Malley AJ; Moen EL
    Cancer Med; 2021 Feb; 10(4):1253-1263. PubMed ID: 33455068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer.
    Veenstra CM; Vachani A; Ciunci CA; Zafar HM; Epstein AJ; Paulson EC
    J Am Coll Radiol; 2016 May; 13(5):491-6. PubMed ID: 26774883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managed care and cancer outcomes for Medicare beneficiaries with disabilities.
    Roetzheim RG; Chirikos TN; Wells KJ; McCarthy EP; Ngo LH; Li D; Drews RE; Iezzoni LI
    Am J Manag Care; 2008 May; 14(5):287-96. PubMed ID: 18471033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
    Davidoff AJ; Gardner JF; Seal B; Edelman MJ
    J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
    Ganti AK; Hirsch FR; Wynes MW; Ravelo A; Ramalingam SS; Ionescu-Ittu R; Pivneva I; Borghaei H
    Clin Lung Cancer; 2017 Nov; 18(6):640-650.e2. PubMed ID: 28522158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based assessment of specialty physician involvement in cancer clinical trials.
    Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
    J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of primary care on breast cancer outcomes among Medicare beneficiaries.
    Roetzheim RG; Ferrante JM; Lee JH; Chen R; Love-Jackson KM; Gonzalez EC; Fisher KJ; McCarthy EP
    Ann Fam Med; 2012; 10(5):401-11. PubMed ID: 22966103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis.
    Onukwugha E; Albarmawi H; Sun K; Mullins CD; Aly A; Hussain A
    Urol Oncol; 2018 Jul; 36(7):340.e23-340.e31. PubMed ID: 29724482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
    Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
    Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
    Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
    JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 40. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.
    Zhu J; Sharma DB; Gray SW; Chen AB; Weeks JC; Schrag D
    JAMA; 2012 Apr; 307(15):1593-601. PubMed ID: 22511687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.